<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Diagnostic Imaging articles</title><description>Diagnostic Imaging articles</description><link>https://www.diagnosticimaging.com/news</link><category>Diagnostic Imaging articles</category><copyright>© 2026 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.</copyright><lastBuildDate>Tue, 17 Nov 2026 20:22:08 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.diagnosticimaging.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Diagnostic Imaging articles</title><width>144</width><height>47</height><link>https://www.diagnosticimaging.com/news</link><url>https://www.diagnosticimaging.com/logo.webp</url></image><item><title>&lt;![CDATA[Reducing Friction in Radiology Workflows with Enterprise Imaging]]&gt;</title><link>https://www.diagnosticimaging.com/view/reducing-friction-radiology-workflows-enterprise-imaging</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/reducing-friction-radiology-workflows-enterprise-imaging</guid><description>&lt;![CDATA[In a recent interview, Collin Bower, BS, RT(R)(CT), discussed how advances in workflow orchestration through enterprise imaging can bolster efficiencies and optimize clinical focus for radiologists.]]&gt;</description><pubDate>Tue, 17 Nov 2026 15:27:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[A Good Story for the Radiologist]]&gt;</title><link>https://www.diagnosticimaging.com/view/good-story-for-radiologist</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/good-story-for-radiologist</guid><description>&lt;![CDATA[More effort and detail on a clinical history may spark reciprocal diligence on imaging interpretation and possibly facilitate earlier detection.]]&gt;</description><pubDate>Mon, 16 Nov 2026 17:56:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Diagnostic Imaging’s Weekly Scan: November 8 — November 14]]&gt;</title><link>https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-november-8-november-14</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-november-8-november-14</guid><description>&lt;![CDATA[Catch up on the top radiology content of the past week.]]&gt;</description><pubDate>Sat, 14 Nov 2026 19:57:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Breast Imaging in Focus: How Does Digital Breast Tomosynthesis Perform Across Different Age Groups?]]&gt;</title><link>https://www.diagnosticimaging.com/view/breast-imaging-in-focus-digital-breast-tomosynthesis-different-age-groups-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/breast-imaging-in-focus-digital-breast-tomosynthesis-different-age-groups-</guid><description>&lt;![CDATA[In the latest episode of her Breast Imaging in Focus series, Manisha Bahl, MD, MPH, FSBI, discussed new research demonstrating that cancer detection rate, sensitivity and positive predictive value (PPV) for digital breast tomosynthesis (DBT) all improved with age.]]&gt;</description><pubDate>Fri, 13 Nov 2026 20:54:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Clears CTA-Based AI Software for Brain Aneurysm Detection and Follow-Up]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-cta-based-ai-software-brain-aneurysm-detection-follow-up</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-cta-based-ai-software-brain-aneurysm-detection-follow-up</guid><description>&lt;![CDATA[Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.]]&gt;</description><pubDate>Fri, 13 Nov 2026 10:56:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Will PCCT Lead the Next Revolution in Interventional Cardiology?]]&gt;</title><link>https://www.diagnosticimaging.com/view/will-pcct-lead-next-revolution-interventional-cardiology-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/will-pcct-lead-next-revolution-interventional-cardiology-</guid><description>&lt;![CDATA[Through enhanced insights into atherosclerotic disease, complex coronary lesions and coronary stents, photon-counting CT provides an anatomical roadmap that may improve outcomes for interventional procedures.]]&gt;</description><pubDate>Thu, 12 Nov 2026 16:02:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-breakthrough-therapy-designation-emerging-psma-pet-agent-men-suspected-pca-recurrence</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-breakthrough-therapy-designation-emerging-psma-pet-agent-men-suspected-pca-recurrence</guid><description>&lt;![CDATA[The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.]]&gt;</description><pubDate>Thu, 12 Nov 2026 10:30:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA]]&gt;</title><link>https://www.diagnosticimaging.com/view/agfa-radiology-ai-powered-dr-100s-pro-x-ray-platform-rsna</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/agfa-radiology-ai-powered-dr-100s-pro-x-ray-platform-rsna</guid><description>&lt;![CDATA[The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.]]&gt;</description><pubDate>Wed, 11 Nov 2026 15:46:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Could an Emerging NacBI-RADS System for mpMRI Bolster Assessment of NAC Response?]]&gt;</title><link>https://www.diagnosticimaging.com/view/emerging-nacbi-rads-system-mpmri-assessment-nac-response-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/emerging-nacbi-rads-system-mpmri-assessment-nac-response-</guid><description>&lt;![CDATA[In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.]]&gt;</description><pubDate>Wed, 11 Nov 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Breast Ultrasound Study: High Glandular Tissue Component May Double Recurrence Risk for Invasive Breast Cancer]]&gt;</title><link>https://www.diagnosticimaging.com/view/breast-ultrasound-study-high-glandular-tissue-component-double-recurrence-risk-invasive-breast-cancer</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/breast-ultrasound-study-high-glandular-tissue-component-double-recurrence-risk-invasive-breast-cancer</guid><description>&lt;![CDATA[A high glandular tissue component on pre-op breast ultrasound may significantly elevate the risk of recurrence for ipsilateral or contralateral breast cancer, according to a newly published study.]]&gt;</description><pubDate>Wed, 11 Nov 2026 00:13:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[CMS Reverses Decision and Issues New Outpatient CPT Code for Ultrasound-Based QTscan ]]&gt;</title><link>https://www.diagnosticimaging.com/view/cms-reverses-decision-issues-new-outpatient-cpt-code-ultrasound-based-qtscan</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/cms-reverses-decision-issues-new-outpatient-cpt-code-ultrasound-based-qtscan</guid><description>&lt;![CDATA[Effective January 1, 2027, use of the QTscan in outpatient diagnostic exams will be reimbursable with the CPT code 1079T.]]&gt;</description><pubDate>Tue, 10 Nov 2026 12:55:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Assessing the Impact of AI-Powered Slab Reconstruction on Reading Time for Digital Breast Tomosynthesis]]&gt;</title><link>https://www.diagnosticimaging.com/view/assessing-impact-ai-powered-slab-reconstruction-reading-time-digital-breast-tomosynthesis</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/assessing-impact-ai-powered-slab-reconstruction-reading-time-digital-breast-tomosynthesis</guid><description>&lt;![CDATA[In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.]]&gt;</description><pubDate>Mon, 09 Nov 2026 22:41:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[A Lyon Among Men: Handling Opportunities to Polish Your Radiology Game]]&gt;</title><link>https://www.diagnosticimaging.com/view/a-lyon-among-men-handling-opportunities-polish-your-radiology-game</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/a-lyon-among-men-handling-opportunities-polish-your-radiology-game</guid><description>&lt;![CDATA[Keeping defensiveness and ego at bay is just one of the attributes of those who consistently embrace learning from others over the course of one’s life.]]&gt;</description><pubDate>Mon, 09 Nov 2026 11:41:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Diagnostic Imaging’s Weekly Scan: November 1 — November 7]]&gt;</title><link>https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-november-1-november-7</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-november-1-november-7</guid><description>&lt;![CDATA[Catch up on the top radiology content of the past week.]]&gt;</description><pubDate>Sun, 08 Nov 2026 19:22:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[New Study Shows Benefits of AI Analysis for Ultrasound Reports and Incidental Findings of Hepatic Steatosis]]&gt;</title><link>https://www.diagnosticimaging.com/view/new-study-ai-analysis-ultrasound-reports-incidental-findings-hepatic-steatosis</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/new-study-ai-analysis-ultrasound-reports-incidental-findings-hepatic-steatosis</guid><description>&lt;![CDATA[In a recent interview, Gadi Lalazar, MD, discussed new research demonstrating the capability of natural language processing (NLP) to enhance recognition of incidental hepatic steatosis in ultrasound reports.]]&gt;</description><pubDate>Sat, 07 Nov 2026 15:25:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Next-Generation Breast Imaging Platform to be Unveiled at RSNA]]&gt;</title><link>https://www.diagnosticimaging.com/view/next-generation-breast-imaging-platform-unveiled-rsna</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/next-generation-breast-imaging-platform-unveiled-rsna</guid><description>&lt;![CDATA[Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.]]&gt;</description><pubDate>Fri, 06 Nov 2026 16:52:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[CCTA Study: AI-Powered Plaque Analysis Reveals Coronary Plaque in 87 Percent of Retired NFL Players]]&gt;</title><link>https://www.diagnosticimaging.com/view/ccta-study-ai-powered-plaque-analysis-coronary-plaque-87-percent-retired-nfl-players</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/ccta-study-ai-powered-plaque-analysis-coronary-plaque-87-percent-retired-nfl-players</guid><description>&lt;![CDATA[Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.]]&gt;</description><pubDate>Thu, 05 Nov 2026 20:48:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[A Closer Look at the P4 Trial and CCTA-Guided PCI]]&gt;</title><link>https://www.diagnosticimaging.com/view/closer-look-p4-trial-ccta-guided-pci</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/closer-look-p4-trial-ccta-guided-pci</guid><description>&lt;![CDATA[While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.]]&gt;</description><pubDate>Thu, 05 Nov 2026 12:02:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[What a New Prospective RCT Reveals About Contrast-Enhanced Mammography in Breast Cancer Staging]]&gt;</title><link>https://www.diagnosticimaging.com/view/new-prospective-rct-contrast-enhanced-mammography-breast-cancer-staging</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/new-prospective-rct-contrast-enhanced-mammography-breast-cancer-staging</guid><description>&lt;![CDATA[While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.

]]&gt;</description><pubDate>Thu, 05 Nov 2026 01:02:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Clears Emerging AI-Enabled Platform for Intravascular Ultrasound]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-clears-emerging-ai-enabled-platform-intravascular-ultrasound</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-clears-emerging-ai-enabled-platform-intravascular-ultrasound</guid><description>&lt;![CDATA[The Evident Vascular Guidance System and Evident peripheral imaging catheters reportedly offer enhanced image clarity and workflow efficiencies for intravascular ultrasound.]]&gt;</description><pubDate>Wed, 04 Nov 2026 19:28:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Addressing Radiology’s Workforce Crisis: Can a Shift from Being Passive AI Users to Active AI Creators Have an Impact? ]]&gt;</title><link>https://www.diagnosticimaging.com/view/addressing-radiology-workforce-crisis-shift-passive-ai-users-active-ai-creators-have-an-impact-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/addressing-radiology-workforce-crisis-shift-passive-ai-users-active-ai-creators-have-an-impact-</guid><description>&lt;![CDATA[Amid the burgeoning imaging volumes and ongoing radiologist shortage, this author suggests that more active involvement by radiologists in the creation and development of AI models could go a long way.]]&gt;</description><pubDate>Wed, 04 Nov 2026 16:54:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Interventional Radiology in Focus: Emerging Concepts with Ablation and Histotripsy in Interventional Oncology]]&gt;</title><link>https://www.diagnosticimaging.com/view/interventional-radiology-emerging-concepts-ablation-histotripsy-interventional-oncology</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/interventional-radiology-emerging-concepts-ablation-histotripsy-interventional-oncology</guid><description>&lt;![CDATA[In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the evolution, research and pearls for ablation procedures, and emerging considerations for histotripsy in the realm of interventional oncology. 

]]&gt;</description><pubDate>Tue, 03 Nov 2026 19:36:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Is Late Arterial Phase CT Necessary for Undifferentiated Acute Abdominal Pain?]]&gt;</title><link>https://www.diagnosticimaging.com/view/late-arterial-phase-ct-undifferentiated-acute-abdominal-pain-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/late-arterial-phase-ct-undifferentiated-acute-abdominal-pain-</guid><description>&lt;![CDATA[New research found that the late arterial phase, which accounts for approximately 40 percent of CT radiation dosing in cases involving acute abdominal pain, offered no exclusive findings that had an impact on clinical care.]]&gt;</description><pubDate>Tue, 03 Nov 2026 11:14:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Could a CCTA-Guided Approach Provide a Viable Alternative to Intravascular Ultrasound Guidance for PCI Procedures?]]&gt;</title><link>https://www.diagnosticimaging.com/view/ccta-guided-approach-viable-alternative-intravascular-ultrasound-guidance-pci-procedures-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/ccta-guided-approach-viable-alternative-intravascular-ultrasound-guidance-pci-procedures-</guid><description>&lt;![CDATA[New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.]]&gt;</description><pubDate>Tue, 03 Nov 2026 01:30:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Simple for a Radiologist, Complex for Everyone Else]]&gt;</title><link>https://www.diagnosticimaging.com/view/simple-for-a-radiologist-complex-for-everyone-else</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/simple-for-a-radiologist-complex-for-everyone-else</guid><description>&lt;![CDATA[Perspective and experience enable us to discern a reasonable explanation prior to boarding a rollercoaster of overreaction.]]&gt;</description><pubDate>Mon, 02 Nov 2026 10:45:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[The Reading Room Podcast: A Closer Look at Comparative Research on PSMA PET Agents in Men with Low PSA Values]]&gt;</title><link>https://www.diagnosticimaging.com/view/reading-room-podcast-comparative-research-psma-pet-agents-men-low-psa-values</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/reading-room-podcast-comparative-research-psma-pet-agents-men-low-psa-values</guid><description>&lt;![CDATA[In a recent podcast episode, Jack Andrews, MD, discussed the role of PSMA PET in facilitating more targeted, metastasis-directed therapy for prostate cancer and recent phase 4 research comparing PSMA PET agents in men with low PSA values.

]]&gt;</description><pubDate>Sat, 31 Oct 2026 16:25:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Diagnostic Imaging&apos;s Weekly Scan: October 25 — October 31]]&gt;</title><link>https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-october-25-october-31</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-october-25-october-31</guid><description>&lt;![CDATA[Catch up on the top radiology content of the past week.

]]&gt;</description><pubDate>Sat, 31 Oct 2026 15:14:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[The Reading Room Podcast: Current Challenges and Emerging Directions in Glioma Imaging]]&gt;</title><link>https://www.diagnosticimaging.com/view/reading-room-podcast-current-challenges-emerging-directions-glioma-imaging</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/reading-room-podcast-current-challenges-emerging-directions-glioma-imaging</guid><description>&lt;![CDATA[In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),]]&gt;</description><pubDate>Sat, 31 Oct 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer]]&gt;</title><link>https://www.diagnosticimaging.com/view/key-features-epni-ct-may-more-than-double-mortality-risk-pancreatic-cancer</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/key-features-epni-ct-may-more-than-double-mortality-risk-pancreatic-cancer</guid><description>&lt;![CDATA[Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI). ]]&gt;</description><pubDate>Fri, 30 Oct 2026 20:13:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[The Reading Room Podcast: Can the PET/CT Agent 124I-Evuzamitide Have an Impact in Detecting Cardiac Amyloidosis?]]&gt;</title><link>https://www.diagnosticimaging.com/view/reading-room-podcast-pet-ct-agent-124i-evuzamitide-detecting-cardiac-amyloidosis-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/reading-room-podcast-pet-ct-agent-124i-evuzamitide-detecting-cardiac-amyloidosis-</guid><description>&lt;![CDATA[In a new podcast episode, Sharmila Dorbala, MD, MPH, shares her insights on recently published phase 3 research examining the use of the PET/CT radiotracer 124I-evuzamitide for bolstering detection of cardiac amyloidosis.]]&gt;</description><pubDate>Fri, 30 Oct 2026 16:15:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item></channel></rss>